CARLYLE GROUP INC
Q3 2023 Form 13-F
THE CARLYLE GROUP reports 632 total accounts under management (AUM). There are 625 discretionary accounts valued at $192,613,890,574, and 7 non-discretionary accounts valued at $51,354,349,773.
Source: Form ADV filed * Note that certain holdings are exempt from Form 13-F reporting, so the AUM totals may be greater than the Form 13-F total.Reports holdings for
- Carlyle Investment Management LLC · File #028-12429 · since Q2 2013
- Abingworth LLP · File #028-14285 · since Q1 2023
- CIM Global L L C · File #028-15024 · since Q2 2013
- Carlyle Global Credit Investment Management L L C · File #028-18762 · Q1 2018 – Q4 2022 · declared by one filing
Holdings reported by
- AlpInvest Partners B V · since Q3 2013
- TCW GROUP INC · since Q2 2013 · declared by one filing
- Abingworth LLP · Q3 2022 – Q4 2022 · declared by one filing
Key People
Form ADV owners & control personsDescription and Activity
Carlyle Group Inc. is a global investment firm managing $426 billion in assets as of December 31, 2023. The company operates through three main business segments: Global Private Equity (GPE), Global Credit (GC), and Global Investment Solutions (GIS). The GPE segment focuses on corporate private equity, real estate, infrastructure, and natural resources, managing $161.3 billion in assets. The GC segment includes various credit strategies such as liquid credit, private credit, and real assets credit, with $187.8 billion in assets. The GIS segment offers investment opportunities through private equity fund of funds, secondary purchases, and managed co-investment programs, totaling $76.9 billion in assets.
Carlyle generates revenue primarily from management fees, performance allocations, and transaction fees associated with its investment funds. Management fees typically range from 1.0% to 2.0% of capital commitments for closed-end carry funds. Carried interest, a share of profits from investments after meeting performance thresholds, is another significant revenue stream. The company's primary customers include institutional investors, pension funds, and high-net-worth individuals. Carlyle operates globally with over 2,200 employees, including 720 investment professionals, across 28 offices. Key factors impacting Carlyle’s business performance include fundraising efforts, investment performance, and market conditions.
Company description summarized from 10-K filing.Filing Navigation
Coverage begins with the second quarter of 2013. Earlier quarters are not shown while their accuracy is being verified.
13F Metrics
Loading 13F Metrics
Q3 2023 13F record
Q3 2023 13F filing summary
| Period of report | September 30, 2023 |
|---|---|
| Filed | November 03, 2023 |
| Form | 13F-HR |
| Reported value | $2.3B |
| Positions | 25 |
| Change in reported value | -17.9% |
| New positions | 2 |
| Exited positions | 3 |
| Position turnover | 17.9% |
| Top-10 concentration | 95.2% |
13F filings by quarter
| Quarter | Positions | Value |
|---|---|---|
|
Q2 2026 13F
Filed Aug 7, 2026
|
19 | $10.0B |
|
Q1 2026 13F
Filed May 8, 2026
|
20 | $10.6B |
|
Q4 2025 13F
Filed Feb 13, 2026
|
20 | $13.6B |
|
Q3 2025 13F
Filed Nov 7, 2025
|
17 | $4.3B |
|
Q2 2025 13F
Filed Aug 8, 2025
|
20 | $5.0B |
|
Q1 2025 13F
Filed May 9, 2025
|
23 | $3.8B |
|
Q4 2024 13F
Filed Feb 13, 2025
|
27 | $4.1B |
|
Q3 2024 13F
Filed Nov 8, 2024
|
26 | $954.2M |
|
Q2 2024 13F
Filed Aug 9, 2024
|
31 | $1.1B |
|
Q1 2024 13F
Filed May 3, 2024
|
32 | $1.6B |
|
Q4 2023 13F
Filed Feb 2, 2024
|
25 | $2.1B |
|
Q3 2023 13F
Filed Nov 3, 2023
|
25 | $2.3B |
|
Q2 2023 13F
Filed Aug 4, 2023
|
26 | $2.8B |
|
Q1 2023 13F
Filed May 5, 2023
|
30 | $3.4B |
|
Q4 2022 13F
Filed Feb 10, 2023
|
13 | $3.4B |
|
Q3 2022 13F
Filed Nov 10, 2022
|
11 | $3.1B |
|
Q2 2022 13F
Filed Aug 12, 2022
|
9 | $5.8B |
|
Q1 2022 13F
Filed May 13, 2022
|
7 | $8.4B |
|
Q4 2021 13F
Filed Feb 11, 2022
|
7 | $9.6B |
|
Q3 2021 13F
Filed Nov 12, 2021
|
10 | $12.6B |
33 earlier quarters on file — choose one from the quarter menu above.
Top 20 holdings · Q3 2023
| # | Holding | Reported value | % of portfolio |
|---|---|---|---|
| 1 | QDEL Quidelortho Corp | $910.1M | 39.47% |
| 2 | GTM ZoomInfo Technologies Inc | $596.6M | 25.88% |
| 3 | MKSI MKS Instrs Inc | $301.4M | 13.07% |
| 4 | VTRU Vitru Ltd | $109.9M | 4.77% |
| 5 | SLNO Soleno Therapeutics Inc | $67.4M | 2.92% |
| 6 | GETY Getty Images Holdings Inc | $63.1M | 2.74% |
| 7 | GDS GDS Hldgs Ltd | $44.6M | 1.93% |
| 8 | VRNA Verona Pharma Plc | $40.0M | 1.74% |
| 9 | PHAT Phathom Pharmaceuticals Inc | $36.2M | 1.57% |
| 10 | HLVX Hillevax Inc | $24.7M | 1.07% |
| 11 | RPHM Reneo Pharmaceuticals Inc | $20.5M | 0.89% |
| 12 | VERA Vera Therapeutics Inc | $19.7M | 0.85% |
| 13 | SMHI Seacor Marine Hldgs Inc | $18.2M | 0.79% |
| 14 | INVH Invitation Homes Inc | $15.1M | 0.66% |
| 15 | CUBE CubeSmart | $8.4M | 0.36% |
| 16 | SPRB Spruce Biosciences Inc | $6.5M | 0.28% |
| 17 | JSPR Jasper Therapeutics Inc | $6.1M | 0.26% |
| 18 | CSLR Complete Solaria Inc. | $5.1M | 0.22% |
| 19 | EM Smart Sh Global Ltd | $3.6M | 0.16% |
| 20 | ACET Adicet Bio Inc | $2.9M | 0.12% |
Values as reported on the Q3 2023 Form 13F. Every position is in the holdings table below.